- Home
- ATNM vs SELF Comparison
ATNM vs SELF Comparison
Compare ATNM & SELF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- SELF
- Stock Information
- Founded
- ATNM 2000
- SELF 1983
- Country
- ATNM United States
- SELF United States
- Employees
- ATNM N/A
- SELF N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- SELF Real Estate Investment Trusts
- Sector
- ATNM Health Care
- SELF Real Estate
- Exchange
- ATNM Nasdaq
- SELF Nasdaq
- Market Cap
- ATNM 50.2M
- SELF 58.8M
- IPO Year
- ATNM N/A
- SELF N/A
- Fundamental
- Price
- ATNM $1.61
- SELF $5.07
- Analyst Decision
- ATNM Strong Buy
- SELF
- Analyst Count
- ATNM 2
- SELF 0
- Target Price
- ATNM $4.50
- SELF N/A
- AVG Volume (30 Days)
- ATNM 122.2K
- SELF 30.0K
- Earning Date
- ATNM 11-13-2025
- SELF 11-07-2025
- Dividend Yield
- ATNM N/A
- SELF 5.70%
- EPS Growth
- ATNM N/A
- SELF 9.99
- EPS
- ATNM N/A
- SELF 0.22
- Revenue
- ATNM N/A
- SELF $12,707,884.00
- Revenue This Year
- ATNM N/A
- SELF N/A
- Revenue Next Year
- ATNM N/A
- SELF N/A
- P/E Ratio
- ATNM N/A
- SELF $23.10
- Revenue Growth
- ATNM N/A
- SELF 4.08
- 52 Week Low
- ATNM $1.03
- SELF $4.78
- 52 Week High
- ATNM $2.41
- SELF $5.89
- Technical
- Relative Strength Index (RSI)
- ATNM 45.72
- SELF 41.94
- Support Level
- ATNM $1.60
- SELF $5.07
- Resistance Level
- ATNM $1.70
- SELF $5.22
- Average True Range (ATR)
- ATNM 0.07
- SELF 0.15
- MACD
- ATNM -0.01
- SELF -0.01
- Stochastic Oscillator
- ATNM 32.14
- SELF 8.69
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About SELF Global Self Storage Inc.
Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops, and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to thirteen self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.